Cue Biopharma
$13.239876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) As of 9:20 AM EDT pre-market
$0.00 (0.00%) Pre-Market
Why Robinhood?
You can buy or sell Cue Biopharma and other stocks, options, ETFs, and crypto commission-free!
About CUE
Cue Biopharma, Inc. Common Stock, also called Cue Biopharma, is a biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Read More Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded on December 31, 2014 and is headquartered in Cambridge, MA.
Employees
47
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
369.41M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
286.74K
High Today
$14.51
Low Today
$13.24
Open Price
$13.60
Volume
266.54K
52 Week High
$22.82
52 Week Low
$6.54
Collections
CUE Earnings
-$0.62
-$0.41
-$0.21
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.40 per share
Actual
-$0.37 per share